A novel peptide, colivelin, prevents alcohol-induced apoptosis in fetal brain of C57BL/6 mice

signaling pathway investigations

Y. Sari, T. Chiba, M. Yamada, G. V. Rebec, S. Aiso

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Fetal alcohol exposure is known to induce cell death through apoptosis. We found that colivelin (CLN), a novel peptide with the sequence SALLRSIPAPAGASRLLLLTGEIDLP, prevents this apoptosis. Our initial experiment revealed that CLN enhanced the viability of primary cortical neurons exposed to alcohol. We then used a mouse model of fetal alcohol exposure to identify the intracellular mechanisms underlying these neuroprotective effects. On embryonic day 7 (E7), weight-matched pregnant females were assigned to the following groups: (1) ethanol liquid diet 25% (4.49% v/v) ethanol derived calories; (2) pair-fed control; (3) normal chow; (4) ethanol liquid diet combined with administration (i.p.) of CLN (20 μg/20 g body weight); and (5) pair-fed combined with administration (i.p.) of CLN (20 μg/20 g body weight). On E13, fetal brains were collected and assayed for TdT-mediated dUTP nick end labeling staining, caspase-3 colorimetric assay, enzyme-linked immunosorbent assay, and Meso scale discovery electrochemiluminescence. CLN blocked the alcohol-induced decline in brain weight and prevented alcohol-induced: apoptosis, activation of caspase-3 and increases of cytosolic cytochrome c, and decreases of mitochondrial cytochrome c Analysis of proteins in the upstream signaling pathway revealed that CLN down-regulated the phosphorylation of the c-Jun N-terminal kinase. Moreover, CLN prevented alcohol-induced reduction in phosphorylation of BAD protein. Thus, CLN appears to act directly on upstream signaling proteins to prevent alcohol-induced apoptosis. Further assessment of these proteins and their signaling mechanisms is likely to enhance development of neuroprotective therapies.

Original languageEnglish
Pages (from-to)1653-1664
Number of pages12
JournalNeuroscience
Volume164
Issue number4
DOIs
Publication statusPublished - 2009 Dec 29

Fingerprint

Inbred C57BL Mouse
Alcohols
Apoptosis
Peptides
Brain
Ethanol
Cytochromes c
Caspase 3
Proteins
Body Weight
Phosphorylation
Diet
Weights and Measures
Colivelin
JNK Mitogen-Activated Protein Kinases
Neuroprotective Agents
Cell Death
Enzyme-Linked Immunosorbent Assay
Staining and Labeling
Neurons

Keywords

  • ADNF-9
  • caspase-3
  • colivelin
  • cytochrome c
  • mitochondria
  • neuroprotection

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

A novel peptide, colivelin, prevents alcohol-induced apoptosis in fetal brain of C57BL/6 mice : signaling pathway investigations. / Sari, Y.; Chiba, T.; Yamada, M.; Rebec, G. V.; Aiso, S.

In: Neuroscience, Vol. 164, No. 4, 29.12.2009, p. 1653-1664.

Research output: Contribution to journalArticle

Sari, Y. ; Chiba, T. ; Yamada, M. ; Rebec, G. V. ; Aiso, S. / A novel peptide, colivelin, prevents alcohol-induced apoptosis in fetal brain of C57BL/6 mice : signaling pathway investigations. In: Neuroscience. 2009 ; Vol. 164, No. 4. pp. 1653-1664.
@article{1c424139af9a48dba44e04bb6eef15cb,
title = "A novel peptide, colivelin, prevents alcohol-induced apoptosis in fetal brain of C57BL/6 mice: signaling pathway investigations",
abstract = "Fetal alcohol exposure is known to induce cell death through apoptosis. We found that colivelin (CLN), a novel peptide with the sequence SALLRSIPAPAGASRLLLLTGEIDLP, prevents this apoptosis. Our initial experiment revealed that CLN enhanced the viability of primary cortical neurons exposed to alcohol. We then used a mouse model of fetal alcohol exposure to identify the intracellular mechanisms underlying these neuroprotective effects. On embryonic day 7 (E7), weight-matched pregnant females were assigned to the following groups: (1) ethanol liquid diet 25{\%} (4.49{\%} v/v) ethanol derived calories; (2) pair-fed control; (3) normal chow; (4) ethanol liquid diet combined with administration (i.p.) of CLN (20 μg/20 g body weight); and (5) pair-fed combined with administration (i.p.) of CLN (20 μg/20 g body weight). On E13, fetal brains were collected and assayed for TdT-mediated dUTP nick end labeling staining, caspase-3 colorimetric assay, enzyme-linked immunosorbent assay, and Meso scale discovery electrochemiluminescence. CLN blocked the alcohol-induced decline in brain weight and prevented alcohol-induced: apoptosis, activation of caspase-3 and increases of cytosolic cytochrome c, and decreases of mitochondrial cytochrome c Analysis of proteins in the upstream signaling pathway revealed that CLN down-regulated the phosphorylation of the c-Jun N-terminal kinase. Moreover, CLN prevented alcohol-induced reduction in phosphorylation of BAD protein. Thus, CLN appears to act directly on upstream signaling proteins to prevent alcohol-induced apoptosis. Further assessment of these proteins and their signaling mechanisms is likely to enhance development of neuroprotective therapies.",
keywords = "ADNF-9, caspase-3, colivelin, cytochrome c, mitochondria, neuroprotection",
author = "Y. Sari and T. Chiba and M. Yamada and Rebec, {G. V.} and S. Aiso",
year = "2009",
month = "12",
day = "29",
doi = "10.1016/j.neuroscience.2009.09.049",
language = "English",
volume = "164",
pages = "1653--1664",
journal = "Neuroscience",
issn = "0306-4522",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - A novel peptide, colivelin, prevents alcohol-induced apoptosis in fetal brain of C57BL/6 mice

T2 - signaling pathway investigations

AU - Sari, Y.

AU - Chiba, T.

AU - Yamada, M.

AU - Rebec, G. V.

AU - Aiso, S.

PY - 2009/12/29

Y1 - 2009/12/29

N2 - Fetal alcohol exposure is known to induce cell death through apoptosis. We found that colivelin (CLN), a novel peptide with the sequence SALLRSIPAPAGASRLLLLTGEIDLP, prevents this apoptosis. Our initial experiment revealed that CLN enhanced the viability of primary cortical neurons exposed to alcohol. We then used a mouse model of fetal alcohol exposure to identify the intracellular mechanisms underlying these neuroprotective effects. On embryonic day 7 (E7), weight-matched pregnant females were assigned to the following groups: (1) ethanol liquid diet 25% (4.49% v/v) ethanol derived calories; (2) pair-fed control; (3) normal chow; (4) ethanol liquid diet combined with administration (i.p.) of CLN (20 μg/20 g body weight); and (5) pair-fed combined with administration (i.p.) of CLN (20 μg/20 g body weight). On E13, fetal brains were collected and assayed for TdT-mediated dUTP nick end labeling staining, caspase-3 colorimetric assay, enzyme-linked immunosorbent assay, and Meso scale discovery electrochemiluminescence. CLN blocked the alcohol-induced decline in brain weight and prevented alcohol-induced: apoptosis, activation of caspase-3 and increases of cytosolic cytochrome c, and decreases of mitochondrial cytochrome c Analysis of proteins in the upstream signaling pathway revealed that CLN down-regulated the phosphorylation of the c-Jun N-terminal kinase. Moreover, CLN prevented alcohol-induced reduction in phosphorylation of BAD protein. Thus, CLN appears to act directly on upstream signaling proteins to prevent alcohol-induced apoptosis. Further assessment of these proteins and their signaling mechanisms is likely to enhance development of neuroprotective therapies.

AB - Fetal alcohol exposure is known to induce cell death through apoptosis. We found that colivelin (CLN), a novel peptide with the sequence SALLRSIPAPAGASRLLLLTGEIDLP, prevents this apoptosis. Our initial experiment revealed that CLN enhanced the viability of primary cortical neurons exposed to alcohol. We then used a mouse model of fetal alcohol exposure to identify the intracellular mechanisms underlying these neuroprotective effects. On embryonic day 7 (E7), weight-matched pregnant females were assigned to the following groups: (1) ethanol liquid diet 25% (4.49% v/v) ethanol derived calories; (2) pair-fed control; (3) normal chow; (4) ethanol liquid diet combined with administration (i.p.) of CLN (20 μg/20 g body weight); and (5) pair-fed combined with administration (i.p.) of CLN (20 μg/20 g body weight). On E13, fetal brains were collected and assayed for TdT-mediated dUTP nick end labeling staining, caspase-3 colorimetric assay, enzyme-linked immunosorbent assay, and Meso scale discovery electrochemiluminescence. CLN blocked the alcohol-induced decline in brain weight and prevented alcohol-induced: apoptosis, activation of caspase-3 and increases of cytosolic cytochrome c, and decreases of mitochondrial cytochrome c Analysis of proteins in the upstream signaling pathway revealed that CLN down-regulated the phosphorylation of the c-Jun N-terminal kinase. Moreover, CLN prevented alcohol-induced reduction in phosphorylation of BAD protein. Thus, CLN appears to act directly on upstream signaling proteins to prevent alcohol-induced apoptosis. Further assessment of these proteins and their signaling mechanisms is likely to enhance development of neuroprotective therapies.

KW - ADNF-9

KW - caspase-3

KW - colivelin

KW - cytochrome c

KW - mitochondria

KW - neuroprotection

UR - http://www.scopus.com/inward/record.url?scp=70449520377&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449520377&partnerID=8YFLogxK

U2 - 10.1016/j.neuroscience.2009.09.049

DO - 10.1016/j.neuroscience.2009.09.049

M3 - Article

VL - 164

SP - 1653

EP - 1664

JO - Neuroscience

JF - Neuroscience

SN - 0306-4522

IS - 4

ER -